Tomohito Doke

8PUBLICATIONS
39CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Tissue engineeringCharacterisation of biological macromoleculesNutrigenomics and personalised nutritionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 23, 2025
Glutathione-specific gamma-glutamylcyclotransferase 1 (CHAC1) increases kidney disease risk by modulating ferroptosis.

Lakshmi P Kolligundla, Katie M Sullivan, Dhanunjay Mukhi

|May 02, 2024
Endothelial-Mesenchymal Transition Switch and Diabetic Kidney Disease.

Tomohito Doke, Petter Bjornstad

|Apr 06, 2023
Unbiased Human Kidney Tissue Proteomics Identifies Matrix Metalloproteinase 7 as a Kidney Disease Biomarker.

Daigoro Hirohama, Amin Abedini, Salina Moon

|Mar 14, 2023
NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury.

Tomohito Doke, Sarmistha Mukherjee, Dhanunjay Mukhi

|Jul 13, 2022
Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration.

Michael S Balzer, Tomohito Doke, Ya-Wen Yang

|Jun 17, 2022
Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease.

Hongbo Liu, Tomohito Doke, Dong Guo

Pageof 2

Frequent Collaborators

7 joint publications

Katalin Susztak

4 joint publications

Hongbo Liu

3 joint publications

Ziyuan Ma

2 joint publications

Xin Sheng